Results 241 to 250 of about 1,323,755 (303)

β2 Adrenoceptor Signaling Modulates Myoblast Differentiation via miR-374b-5p/GSK3β and miR-326-3p/Tnfrsf11a Axes. [PDF]

open access: yesCell Biol Int
Koike TE   +10 more
europepmc   +1 more source

Trip killers: Addressing a critical knowledge gap in psychedelic research. [PDF]

open access: yesJ Psychopharmacol
O'Mahony B   +3 more
europepmc   +1 more source

International Utah cardiac recovery symposium (U-CARS) 2025:translational and basic science proceedings. [PDF]

open access: yesHeart Fail Rev
Visker JR   +5 more
europepmc   +1 more source

Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study. [PDF]

open access: yesPharmaceuticals (Basel)
Solomon CC   +11 more
europepmc   +1 more source

Beta adrenergic receptors in lymphocyte subpopulations

open access: yesJournal of Allergy and Clinical Immunology, 1980
To further evaluate the potential utility of lymphocyte beta adrenergic receptor assays in the study of receptor alterations in human disease, we studied highly purified populations of B and T lymphocytes in peripheral blood to see if differences existed in the concentration or affinity of beta adrenergic receptors and catecholamine-responsive cAMP ...
N H, Bishopric   +2 more
openaire   +3 more sources

Reduction of beta-adrenergic receptors by tertatolol: An additional mechanism for beta-adrenergic blockade

open access: yesClinical Pharmacology and Therapeutics, 1986
Tertatolol is a potent new beta-blocker with no intrinsic sympathomimetic activity or beta 1/beta 2-receptor subtype selectivity. When given at therapeutic doses (5 mg/day) to human subjects it induced a reduction in the beta-adrenergic receptor number measured by 3H-CGP 12177 specific binding, without any change in the affinity on intact lymphocytes ...
DE BLASI, ANTONIO   +5 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy